JP2025182116A5 - - Google Patents
Info
- Publication number
- JP2025182116A5 JP2025182116A5 JP2025169943A JP2025169943A JP2025182116A5 JP 2025182116 A5 JP2025182116 A5 JP 2025182116A5 JP 2025169943 A JP2025169943 A JP 2025169943A JP 2025169943 A JP2025169943 A JP 2025169943A JP 2025182116 A5 JP2025182116 A5 JP 2025182116A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation according
- physiologically active
- matrix
- cannabinoids
- highly lipophilic
- Prior art date
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19203580.6A EP3808341A1 (de) | 2019-10-16 | 2019-10-16 | Kontrolliert freisetzende formulierungen stark lipophiler physiologisch aktiver substanzen |
| EP19203580.6 | 2019-10-16 | ||
| PCT/EP2020/079248 WO2021074403A1 (de) | 2019-10-16 | 2020-10-16 | Kontrolliert freisetzende formulierungen stark lipophiler physiologisch aktiver substanzen |
| JP2022521684A JP7778069B2 (ja) | 2019-10-16 | 2020-10-16 | 高親油性生理活性物質の放出制御製剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521684A Division JP7778069B2 (ja) | 2019-10-16 | 2020-10-16 | 高親油性生理活性物質の放出制御製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025182116A JP2025182116A (ja) | 2025-12-11 |
| JP2025182116A5 true JP2025182116A5 (https=) | 2026-05-01 |
Family
ID=68281185
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521684A Active JP7778069B2 (ja) | 2019-10-16 | 2020-10-16 | 高親油性生理活性物質の放出制御製剤 |
| JP2025169943A Pending JP2025182116A (ja) | 2019-10-16 | 2025-10-08 | 高親油性生理活性物質の放出制御製剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521684A Active JP7778069B2 (ja) | 2019-10-16 | 2020-10-16 | 高親油性生理活性物質の放出制御製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240139215A1 (https=) |
| EP (2) | EP3808341A1 (https=) |
| JP (2) | JP7778069B2 (https=) |
| CN (1) | CN114945353A (https=) |
| AU (1) | AU2020365443A1 (https=) |
| BR (1) | BR112022006643A2 (https=) |
| CA (1) | CA3157654A1 (https=) |
| IL (1) | IL292018A (https=) |
| MX (1) | MX2022004523A (https=) |
| WO (1) | WO2021074403A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3808336A1 (de) * | 2019-10-16 | 2021-04-21 | ADD Advanced Drug Delivery Technologies, Ltd. | Kontrolliert freisetzende formulierungen stark lipophiler physiologisch aktiver substanzen |
| US20240317701A1 (en) | 2020-12-17 | 2024-09-26 | Nalu Bio, Inc. | Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use |
| GB2618322A (en) * | 2022-04-29 | 2023-11-08 | 113 Botanicals Ltd | Compositions and methods |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1361864T3 (en) * | 2001-02-14 | 2014-03-03 | Gw Pharma Ltd | FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids |
| EP1364646A4 (en) * | 2001-03-01 | 2005-08-03 | Grelan Pharmaceutical Co | FENOFIBRATE CONTAINING COMPOSITION |
| DE10226494A1 (de) * | 2002-06-14 | 2004-01-08 | Lts Lohmann Therapie-Systeme Ag | Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen |
| WO2008024490A2 (en) | 2006-08-24 | 2008-02-28 | Theraquest Biosciences, Inc. | Oral pharmaceutical formulations of abuse deterrent cannabinoids and method of use |
| AU2014340709B2 (en) | 2013-10-29 | 2019-07-04 | Echo Pharmaceuticals B.V. | Compressed tablet containing cannabidiol, method for its manufacture and use of such tablet in oral treatment of psychosis or anxiety disorders |
| DE102014213548A1 (de) * | 2014-07-11 | 2016-01-14 | Hans Brammer | Cannabispräparat |
| HRP20200326T1 (hr) * | 2014-08-11 | 2020-06-12 | Perora Gmbh | Formulacija koja sadrži čestice |
| IL246790A0 (en) * | 2016-07-14 | 2016-09-29 | Friedman Doron | Self-dissolving compounds of cannabinoids |
| WO2018035030A1 (en) | 2016-08-15 | 2018-02-22 | Corr-Jensen Inc. | Time release fat-soluble actives |
| JP2019137614A (ja) * | 2018-02-06 | 2019-08-22 | 富士フイルム株式会社 | 経口用医薬組成物及びその製造方法 |
| DE102019100483A1 (de) * | 2019-01-10 | 2020-07-16 | Lts Lohmann Therapie-Systeme Ag | Oraler Dünnfilm |
-
2019
- 2019-10-16 EP EP19203580.6A patent/EP3808341A1/de not_active Withdrawn
-
2020
- 2020-10-16 MX MX2022004523A patent/MX2022004523A/es unknown
- 2020-10-16 AU AU2020365443A patent/AU2020365443A1/en active Pending
- 2020-10-16 US US17/769,424 patent/US20240139215A1/en active Pending
- 2020-10-16 CN CN202080072328.8A patent/CN114945353A/zh active Pending
- 2020-10-16 WO PCT/EP2020/079248 patent/WO2021074403A1/de not_active Ceased
- 2020-10-16 BR BR112022006643A patent/BR112022006643A2/pt unknown
- 2020-10-16 JP JP2022521684A patent/JP7778069B2/ja active Active
- 2020-10-16 EP EP20800800.3A patent/EP4045014A1/de active Pending
- 2020-10-16 IL IL292018A patent/IL292018A/en unknown
- 2020-10-16 CA CA3157654A patent/CA3157654A1/en active Pending
-
2025
- 2025-10-08 JP JP2025169943A patent/JP2025182116A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025182116A5 (https=) | ||
| AU2020300624B2 (en) | Sustained release compositions of endoxifen | |
| JPS58403B2 (ja) | Ｌ− アスコルビンサンセイザイノ セイゾウホウ | |
| CN101028254B (zh) | 一种多索茶碱缓释制剂及其制备方法 | |
| JP2025182116A (ja) | 高親油性生理活性物質の放出制御製剤 | |
| CN106924199A (zh) | 包含阿卡波糖的口腔崩解片 | |
| AU698784B2 (en) | Alkalinizing potassium salt controlled release preparations | |
| CN101756981B (zh) | 一种布洛氯雷伪麻缓释制剂及其制备方法 | |
| WO2011026312A1 (zh) | 一种含有美托洛尔琥珀酸盐的新型骨架缓释片 | |
| JP6866136B2 (ja) | デュロキセチン塩酸塩を含む口腔内崩壊錠 | |
| CN103768034A (zh) | 一种含有盐酸安非他酮的缓控释固体组合物 | |
| CN103181886A (zh) | 一种青蒿素或其衍生物的缓释制剂及其制备方法 | |
| CN101244068B (zh) | 雪胆素缓释制剂 | |
| CN101658507A (zh) | 一种愈创木酚甘油醚和伪麻黄碱的复方缓释制剂 | |
| JPWO2021074403A5 (https=) | ||
| CN101780094B (zh) | 雪胆素缓释制剂 | |
| WO2017064814A1 (ja) | ジエノゲスト含有錠剤 | |
| CN105560200A (zh) | 难溶性药物控释片及其制备方法 | |
| CN105616370A (zh) | 一种雷诺嗪缓释片药物组合物及其制备方法 | |
| CN103800326B (zh) | 一种泮托拉唑钠药物组合物、含有该组合物的微丸及其制备方法 | |
| CN101829121B (zh) | 雪胆素缓释制剂 | |
| US12558391B2 (en) | Sustained release formulation containing Aspalathus linearis extract | |
| Ayesha Farhana et al. | Sustained release of verapamil hydrochloride from sodium alginate microcapsules | |
| CN121041272A (zh) | 丁苯酞固体释药体系及其制备方法和药物片剂 | |
| CN103371983A (zh) | 基于溶蚀渗透机理的硫酸沙丁胺醇控释制剂 |